Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PTBaileyon Nov 17, 2021 12:01pm
168 Views
Post# 34136586

RE:Who still likes share splits and endless promises?

RE:Who still likes share splits and endless promises?
Kobedog1 wrote: Covid will be over before these empty suits get their act together. 
This has been a life lesson for me and I really thought there were no more life lessons for me.
When a name change and a share split is in the wind, it will end up as gas.
Honestly. Dump and run. Holding is painful. 
The last promoter that did this cost me a lot of money. He has been investigated and may now be in jail. A  new suit , self indulgent Torontonian. Even called me in the end. The only pleasure I got was hanging up on him. 

Now I have said my piece. Learn or get burned. That is the great lesson in life. 
The decision to sell is much more important than any decision to buy.
Embrace this and understand what it means. And then act when in doubt.

Sounds easy, doesn't it?  Repeat  Selling decisions are way more important than buying decisions.
Anybody can buy.  But when to sell?  That is the magic decision.
Best wishes to the honest folks on this board.
Kobe from Niagara.


"Selling decisions are way more important than buying decisions." So true and great point.

I don't think Covid is where the greatest potential is anymore but the focus on the varants and PAH. In particular PAH is a very large market and R-107 not just addresses it but reverses the damange accroding to studies I have seen.


https://claritasinvestors.com/index.php?/topic/1074-r-107-stops-pah-progression-reverses-hypertension-in-rats/#comment-3654
<< Previous
Bullboard Posts
Next >>